Literature DB >> 4199417

Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.

P J Snyder, R D Utiger.   

Abstract

Repetitive administration of thyrotropin-releasing hormone (TRH) to human subjects was used to produce small elevations of endogenous serum triiodothyronine (T(3)) and thyroxine (T(4)) levels and thereby to determine the effect of these small elevations on the serum thyrotropin (TSH) response to subsequent doses of TRH. Each subject received 13 consecutive doses of 25 mug TRH at 4-h intervals. Serum T(3), T(4), and TSH levels were measured before the 1st, 7th, and 13th doses ("basal levels") and for the 4 h after each of these doses. In 10 normal subjects, the mean TSH response fell from 14.6 muU/ml after the 1st TRH dose to 6.9 and 3.0 muU/ml after the 7th, and 13th doses. These falls in TSH response were accompanied by rises in the mean basal serum T(3) levels from 81 to 115 to 114 ng/100 ml (normal range, 70-150 ng/100 ml) and rises in the mean basal serum T(4) from 6.7 to 8.6 to 9.5 mug/100 ml (normal range, 5-11 mug/100 ml). These data suggest that TRH-induced TSH release is extremely sensitive to inhibition by small elevations, not above the normal ranges, of serum T(3) and T(4) of endogenous origin. In four patients with primary hypothyroidism, the mean TSH responses were 92, 137, and 92 muU/ml after the 1st, 7th, and 13th TRH doses. The corresponding mean basal serum T(3) and T(4) levels at the times of these doses were 34, 30, and 32 ng/100 ml and 1.9, 1.9, and 1.7 mug/100 ml. These data show that repetitive administration of TRH does not result in progressively lower TSH responses in the absence of corresponding increases in serum T(3) and T(4) level. The progressive fall in TSH response observed in the normal subjects, therefore, was apparently due to the corresponding small increases in serum T(3) and T(4) levels and not to progressive depletion of pituitary TSH. In two patients with presumed TRH deficiency, the TSH responses were blunted by repetitive TRH doses but only when the serum T(3) and T(4) levels increased to within the normal ranges. TRH deficiency was thus confirmed for the first time by producing euthyroidism by replacement of TRH.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4199417      PMCID: PMC333035          DOI: 10.1172/JCI107419

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING.

Authors:  B E MURPHY; C J PATTEE
Journal:  J Clin Endocrinol Metab       Date:  1964-02       Impact factor: 5.958

2.  Estimation of thyroxine binding protein capacities using a non-electrophoretic technique.

Authors:  P M Keane; P J Pegg; E Johnson
Journal:  J Clin Endocrinol Metab       Date:  1969-08       Impact factor: 5.958

Review 3.  Studies of thyrotropin physiology by means of radioimmunoassay.

Authors:  W D Odell; J F Wilber; R D Utiger
Journal:  Recent Prog Horm Res       Date:  1967

4.  The arginine provocative test: an aid in the diagnosis of hyposomatotropism.

Authors:  M L Parker; J M Hammond; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1967-08       Impact factor: 5.958

5.  The thyrotrophin stimulation test.

Authors:  G Burke
Journal:  Ann Intern Med       Date:  1968-12       Impact factor: 25.391

6.  Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man.

Authors:  M S Anderson; C Y Bowers; A J Kastin; D S Schalch; A V Schally; P J Snyder; R D Utiger; J F Wilber; A J Wise
Journal:  N Engl J Med       Date:  1971-12-02       Impact factor: 91.245

7.  Direct evaluation of pituitary thyrotopin reserve utilizing synthetic thyrotopin releasing hormone.

Authors:  E D Haigler; J A Pittman; J M Hershman; C M Baugh
Journal:  J Clin Endocrinol Metab       Date:  1971-10       Impact factor: 5.958

8.  Hypothalamic hypothyroidism.

Authors:  J A Pittman; E D Haigler; J M Hershman; C S Pittman
Journal:  N Engl J Med       Date:  1971-10-07       Impact factor: 91.245

9.  Further observations on the effect of synthetic thyrotropin-releasing hormone in man.

Authors:  B J Ormston; J R Kilborn; R Garry; J Amos; R Hall
Journal:  Br Med J       Date:  1971-04-24

10.  Effect of thyrotropin-releasing factor on serum thyroid-stimulating hormone. An approach to distinguishing hypothalamic from pituitary forms of idiopathic hypopituitary dwarfism.

Authors:  B H Costom; M M Grumbach; S L Kaplan
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

View more
  4 in total

1.  Pulsatile secretion of thyrotropin in children.

Authors:  S Loche; V Cherubini; E Bartolotta; A Lampis; D Carta; P Tomasi; C Pintor
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

2.  Assessment of Thyroid Function and Oxidative Stress State in Foundry Workers Exposed to Lead.

Authors:  Yosri A Fahim; Nevin E Sharaf; Ibrahim W Hasani; Eman A Ragab; Heba K Abdelhakim
Journal:  J Health Pollut       Date:  2020-08-19

Review 3.  Psychoneuroendocrine research in depression. II. Hormonal responses to releasing hormones as a probe for hypothalamic-pituitary-endorgan dysfunction.

Authors:  K P Lesch; R Rupprecht
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations.

Authors:  A G Vagenakis; B Rapoport; F Azizi; G I Portnay; L E Braverman; S H Ingbar
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.